The invention discloses a cefotiam-
hydrochloride-containing
medicine preparation which is composed of an
active component cefotiam hydrochloride, basic
amino acid, and
anhydrous sodium carbonate. The weight ratio of
cefotiam hydrochloride (calculated according to cefotiam) to basic
amino acid to
anhydrous sodium carbonate is 1:0.4-0.6:0.05-0.15. A preparation method provided by the invention is substantially advantaged in that: (1)
vacuum pumping is not needed after product sub-packaging, such that processes are reduced; (2) when the
medicine is dissolved, the generation of a large amount of
carbon dioxide is prevented, such that the danger for cefotiam
medicine liquid to be sprayed from a
bottle is avoided; (3) when the cefotiam preparation is diluted into various fluid replacements (including glucose solutions,
electrolyte solutions or
amino acid preparations), the amount of generated
carbon dioxide is extremely low, such that
clarity observation of intravenous infusion is not affected; (4) the dosage of
anhydrous sodium carbonate is low, such that the possibility of alkalosis is avoided; and (5) the dosage of sodium ions is reduced, such that the preparation is suitable for patients with cardiac or renal insufficiency,
edema patients, neonates, pregnant women, and the aged. Therefore, the application scope of the preparation is expended.